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Six different batches of the glutamic acid analogue quisqualic acid were analyzed with high-pressure liquid chromatography 
(HPLC). All batches examined showed contaminant peaks. Different batches had different contaminant peaks and differing amounts 
of each contaminant. Every batch of quisqualic acid tested demonstrated a contaminant peak which co-eluted with exogenously 
added glutamic acid. Certain batches possessed a contaminant which co-eluted with aspartic acid. The levels of glutamate-like 
contamination ranged from 0.08 to 0.60%, and the levels of aspartate-like contamination ranged from undetectable amounts to 0.80%. 
The amount of combined glutamate- and aspartate-like contamination of each batch of quisqualate correlated very highly with the 
ability of that batch to interact with non-quisqualate receptors in an autoradiographic binding assay. These non-quisqualate receptors 
are likely N-methyl-D-aspartate (NMDA) receptors. Thus, when high concentrations of quisqualate are used experimentally, 
contamination is likely to produce spurious effects at non-quisqualate glutamate receptors. Quisqualate itself may be a more specific 
agonist than assumed previously. 
Introduction 
Quisqual ic  acid is an ana logue  of g lu tamic  acid  
which preferen t ia l ly  in teracts  with the quisqua la te  
sub type  of g lu t ama te  receptors  (Watk ins  and 
Evans, 1981). At  re la t ively high concent ra t ions ,  
qu isqua la te  in terac ts  wi th  N-methy l -D-aspa r t a t e  
( N M D A ) - t y p e  g lu tama te  receptors  (O lve rman  et 
al., 1984; G r e e n a m y r e  et al., 1985; Fos te r  and  
Fagg,  1987; Cha  et al., 1988). Quisqua la te  m a y  
interact  with N M D A  receptors  as a non-select ive  
agonist ,  or, a l ternat ively,  there may  be con tami -  
nan t  amino  acids presen t  in qu isqua la te  p r epa ra -  
tions, such that  at high concen t ra t ions  of quis-  
qualate ,  the con taminan t s  in teract  with N M D A  
receptors .  Commerc ia l ly  avai lable  qu isqua la te  is 
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e i ther  synthes ized or pur i f ied  f rom the berries of 
Quisqua l i s  ind ica  and  Q. f r u c t u s  via a process  by 
which small  quant i t ies  of na tura l ly  occurr ing 
g lu tama te  and a spa r t a t e  might  remain  in the final 
p roduc t .  We  repor t  the presence of con t aminan t s  
which behave  ident ica l ly  to g lu tamate  and aspar-  
tare in HPLC.  We have also examined  the correla-  
t ion be tween the a m o u n t  of c on t a mina t i on  in dif- 
ferent  ba tches  of  qu i squa la te  and  the po tency  of 
those ba tches  in d i sp lac ing  [3H]glu tamate  in an 
a u t o r a d i o g r a p h i c  b ind ing  assay. 
A p re l imina ry  repor t  has been publ i shed  (Cha 
et al., 1987). 
Materials and Methods 
M a t e r i a l s  
Quisqual ic  acid  was ob t a ined  from Sigma (St. 
Louis ,  MO),  Research  Biochemicals  (Wayland ,  
MA)  and C a m b r i d g e  Research  Biochemicals  (Val- 
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ley Stream, NY). Additional synthetic quisqualic 
acid was a generous gift from Dr. J.F. Collins. 
I.-[3H]Glutamic acid (specific activity 36 to 53 
Ci /mmol)  was obtained from Amersham (Arling- 
ton Heights, IL). All other compounds were 
purchased from Sigma. All solvents were of HPLC 
grade. 
High-pressure liquid chromatography ( H P LC) 
HPLC analysis was performed using a reverse 
phase C18 column and gradient elution. The 
organic phase was methanol : acetonitrile : tetrahy- 
drofuran ( 5 : 4 : 1 )  and the aqueous phase was 50 
mM sodium acetate, pH 5.0. For gradient elution, 
the initial percent organic phase was 32%, with a 
flow rate of 0.5 mi rain -1. At t = 9  min, the 
percentage of organic phase was increased in a 
linear fashion while maintaining the same flow 
rate. When the percent organic phase reached 80% 
at t = 13 min, the percent of organic phase was 
linearly reduced to 32% over the next 6 min. 
Thereafter, the percent organic phase remained at 
32%. Amino acids were derivatized precolumn with 
O-phthaldialdehyde/ethanethiol  (Fernstrom and 
Fernstrom, 1981), injected in a sample volume of 
10 /~L and were detected fluorometrically, with an 
emission filter cut off of 470 nm. Quantification of 
contaminants was carried out by adding increas- 
ing concentrations of either L-aspartate or L- 
glutamate to samples of quisqualate and perfor- 
ming linear regression analysis on the resultant 
peak heights. 
Receptor autoradiography 
A detailed description of the method for 
glutamate receptor autoradiography has been pub- 
lished (Greenamyre et al., 1984, 1985). Briefly, 
male Sprague-Dawley rats (175-250 g) were de- 
capitated, and the brains quickly removed and 
frozen under powdered dry ice. Twenty/~m cryo- 
stat sections were thaw-mounted onto gelatin- 
coated slides. In order to remove endogenous 
glutamate, all sections underwent a prewash for 30 
rain at 2 °C in 50 mM Tris-HC1 buffer containing 
2.5 mM CaC12, pH 7.20. Tissues were incubated 
for 45 min at 2 °C  with 20 concentrations (1 
nM-1 mM) of quisqualate in the presence of 200 
nM L-[3H]glutamate. 
After the incubation, sections were rinsed 
quickly with cold buffer, then cold 2.5c,~ 
glutaraldehyde in acetone (v/v),  and blown dry 
with warm air. Dried sections were placed in 
cassettes with radioactive standards and apposed 
to LKB Ultrofilm 3H. The film was exposed to the 
tissue sections for 14 to 21 days at 4°C.  then 
developed, fixed and dried. All data presented 
were analyzed densitometrically from resultant au- 
toradiographic images. Twenty-three sections in- 
cubated in 20 different concentrations of quisqua- 
late were analyzed from each of 4 individual 
animals for each batch of quisqualate. Sixteen to 
25 density readings were taken from the striatum 
of each tissue section. K i values were determined 
by the computer program LIG A N D  (Munson and 
Rodbard, 1980). 
Results 
Contaminants detected by HPLC 
In our HPLC system, glutamate, aspartate, and 
quisqualate appear as separate resolvable peaks. 
The quisqualate peaks appear quite large, relative 
to the contaminant peaks, as it was necessary to 
use high concentrations of quisqualate in order to 
determine accurately the concentration of con- 
taminants. N MD A  was not detectable in our sys- 
tem, which employs derivatization of the free 
amino group of amino acids. 
Six different batches of quisqualate from four 
separate sources were tested. Every batch tested 
had small contaminant peaks detectable by HPLC. 
These peaks were not present in control samples 
which omitted quisqualate. Batches differed in the 
number of these peaks and their sizes (Fig. 1). All 
quisqualate preparations also showed signs of con- 
tarnination in thin layer chromatography (data not 
shown). 
All batches of quisqualate tested were found to 
possess a peak which co-eluted with exogenously 
added glutamate (Fig. 2). In order to quantify the 
amount of this 'glutamate-like' contaminant, sam- 
ples of quisqualate (333 pmol) were chromato- 
graphed along with various concentrations (0, 1.67, 
3.33, and 5 pmol) of glutamate in a sample volume 
of 10 /~1. The percentage of glutamate-like con- 
taminant ranged from 0.08 to 0.60%. 
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Fig. 1. High-pressure liquid chromatography records of 6 different quisqualate preparations. Dotted line represents percentage 
organic phase. Aqueous phase was 50 mM sodium acetate, pH 5.0. Organic phase was methanol:acetonitrile:tetrahydrofuran 
(5:4: 1). Quisqualate preparations: A: Sigma 26F-0056; B: Sigma 106F-0622: C: Sigma 55F-0015; D: CRB A005/2177; E: RBI 
JC-487: F: synthetic (from J. Collins). All batches demonstrate contaminant peaks. The amount of contamination varies from batch 
to batch. 
Three of  the batches were found to possess a 
peak which co-eluted with exogenously added 
aspartate, and the amount  of  'aspartate- l ike '  con- 
taminant  was determined in the same fashion as 
for glutamate. The percentage of aspartate-like 
contaminant  ranged f rom 0.34 to 0.85% (Table I). 
N o  aspartate-like contaminant  was detected in 
synthetic quisqualate preparations,  only in quis- 
qualate preparat ions isolated f rom natural  sources. 
Behavior of different quisqualate preparations in a 
glutamate-binding assay 
Quisqualate displaces L-[3H]glutamate binding 
in a biphasic manner,  with the 'h igh-aff ini ty '  corn- 
Fig. 2. Contaminant peak which behaves like glutamate. A: 
333.3 pmol quisqualate (Sigma batch 106F-0622), demon- 
strating a large quisqualate peak with several smaller contami- 
nant peaks. B: 333.3 pmol quisqualate with 1.667 pmol exoge- 
nously added glutamate. The added glutamate co-elutes with 
one of the contaminant peaks, indicated with an arrow. Each 
preparation of quisqualate tested had a peak which co-eluted 
with exogenously added glutamate. In a similar fashion, some 
preparations of quisqualate had other contaminant peaks which 
co-eluted with exogenously added aspartate. 
p o n e n t  r e p r e s e n t i n g  d i s p l a c e m e n t  o f  L- 
[ 3 H ] g l u t a m a t e  f r o m  q u i s q u a l a t e  r ecep to r s  
(Greenamyre  et al., 1985; Olson et al., 1987; Cha 
et al., 1988). The por t ion of  L-[3H]glutamate bi- 
nding which has low affinity for quisqualate likely 
represents g lutamate  binding to N M D A  receptors 
(Greenamyre  et al., 1985, 1987; Foster and Fagg, 
1987; Cha  et al., 1988). Thus  the K i value for the 
'h igh-aff in i ty '  por t ion  of  the quisqualate displace- 
ment  curve reflects the po tency  of  a given batch of 
quisqualate at quisqualate receptors, whereas the 
K~ value for the ' low-aff ini ty '  por t ion represents 
interaction with 'non-quisqua la te '  (likely N M D A )  
receptors. 
All six batches of  quisqualate tested produced a 
biphasic displacement  curve of L-[3H]glutamate, 
as expected. High-affini ty K i values of the 6 
quisqualate preparat ions  were not significantly 
different f rom each other  ( P  > 0.05, by one-way 
ANOVA) ,  indicating that they all possessed simi- 
lar potency at quisqualate receptors. In contrast,  
the low-affinity K i values were significantly dif- 
ferent f rom each other ( P  <0 .05  by one way 
A N O V A ,  ~.18 = 3.467), indicating that different 
batches had differing potencies at non-quisqualate  
receptors (Table I). 
Al though glutamate  and aspartate are both 
agonists at N M D A  receptors, they do not possess 
identical affinities. Thus,  under  the present assay 
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TABLE I 
LEVELS OF G L U T A M A T E  A N D  ASPARTATE C O N T A M I N A T I O N ,  A N D  K~ VALUES IN 6 D I F F E R E N T  PREPARATIONS 
OF Q U I S Q U A L A T E  
K i values represent mean  + S.E.M. of 4 animals. There were no significant differences at the 'high-affinity '  site, but batches had 
significantly different affinities at the ' low-affinity'  site. GLU-like = glutamate-like contaminant ,  ASP-like = aspartate-like contami- 
nant. 
Quisqualate preparation Contaminat ion (%) K i values 
Supplier Batch GLU-tike ASP-like G L U  + (0.125) ASP 'High  affinity' (nM) 'Low affinity' (/~M) 
Sigma 55F-0015 0.45 0.80 0.55 14.74_+ 2.85 26.97 ± 6.96 
Sigma 106F-0622 0.29 0.76 0.38 25.43 + 11.10 74.40 + 17.10 
Sigma 26F-0056 0.59 0.34 0.63 33.78+ 7.65 110.5 ± 36.9 
CRB A005/2177 0.13 * 0.13 10.36 + 6.20 252.0 ± 125.0 
RBI JC-487 0.25 * 0.25 86.37 + 42.44 t 256.0 ± 30.0 
Dr. J. Collins Synthetic 0.08 * 0.08 29.54 ± 9.65 227.6 ± 53.7 
* Not detectable, i.e. less than 200 fmol of contaminant  in 333.3 pmol  of quisqualate sample, t n = 3 animals. 
conditions, glutamate has a K~ value vs. NMDA 
binding which is eight times more potent than that 
of aspartate: 200 nM for glutamate vs. 1.6/~M for 
aspartate (Greenamyre et al., 1985). Aspartate-like 
contaminants would be expected to make a rela- 
tively weaker contribution than glutamate-like 
contaminants in displacing [3H]glutamate binding 
from non-quisqualate receptors. There was an ex- 
cellent correlation between the percentage of 
glutamate-like contamination plus one-eighth of 
the percentage of aspartate-like contamination vs 
the low affinity g i Of a given batch of quisqualate 
(r  = 0.86) (Fig. 3). 
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Fig. 3. Correlation of behavior of quisqualate preparations in a 
glutamate-binding assay with percentage contamination. The 
'low-affinity' K, values correlated very highly with (% of 
glutamate-like contaminant + (0.125) (% aspartate-like con- 
taminant)). Both glutamate and aspartate are known to inter- 
act with the NMDA receptor, but aspartate has one-eighth the 
affinity of glutamate. The Pearson correlation coefficient r = 
0.86. 
Discussion 
In 1984, Olverman et al. reported the presence 
of glutamate in quisqualate as detected by high 
voltage paper  electrophoresis. We report here de- 
tectable contamination using HPLC. Further, we 
report several HPLC-resolvable contaminant peaks 
in each batch of quisqualate tested. One of these 
contaminant peaks co-elutes with aspartate. This 
aspartate-like material was present only in quis- 
qualate isolated from natural sources, whereas the 
glutamate-like contaminant appeared in all batches 
tested, whether the quisqualate had been synthe- 
sized or isolated from natural sources. 
Different batches of quisqualate behaved dif- 
ferently in a bioassay: an autoradiographic 
[3H]glutamate-binding assay. Importantly, at low 
concentrations, at which the absolute levels of 
contaminants would be negligible, all batches of 
quisqualate possessed the same potency at quis- 
qualate receptors. At higher concentrations of 
quisqualate, where the concentration of contami- 
nants also rises, the quisqualate preparations dif- 
fered from each other in their ability to interact 
with non-quisqualate receptors. The variable 
potency of quisqualate at non-quisquatate recep- 
tors suggests that it is the level of glutamate/  
aspartate contamination, rather than an intrinsic 
action of quisqualate itself, which explains the 
apparent affinity of quisqualate for non-quisqua- 
late receptors. The apparent potency of quisqua- 
late at NMDA receptors would be expected to 
vary if the effect were mediated by contaminants, 
since the concentration of contaminants would be 
likely to vary from batch to batch. The contami- 
nant hypothesis is greatly strengthened by the 
finding that the potency of batches of quisqualate 
at non-quisqualate receptors correlates extremely 
well with the percentage of glutamate and aspar- 
tate contamination in these quisqualate prepara- 
tions. 
Certain commercially available quisqualate pre- 
parations (Sigma) are isolated from natural sources 
via a process which could leave residual aspartate 
and glutamate (see, e.g. Takemoto et al., 1975a). 
We have been able to detect contaminants which 
behave identically to aspartate and glutamate in 
these samples. Other quisqualate preparations 
(Cambridge Research Biochemicals, Research Bio- 
chemicals) are synthesized chemically. The best 
known schemes for quisqualate synthesis employ 
no glutamate in the process, and it is unlikely that 
any glutamate is formed as a side product (for 
examples, see Takemoto et al., 1975b; Bycroft et 
al., 1984). Thus, the appearance of glutamate-like 
contaminants in these batches was surprising. 
However, contaminant glutamate may derive from 
slightly contaminated starting materials and be 
carried throughout the synthetic procedure. It is 
relevant to note that we have employed a criterion 
for purity in the present study which exceeds that 
normally used in commercial preparative proce- 
dures. No aspartate-like contaminant was detected 
in any of the synthetic quisqualates, and in gen- 
eral, they possessed fewer contaminant peaks. Al- 
though purified natural quisqualate contains only 
the L-isomer, synthetic preparations might contain 
a racemic mixture of D- and L-isomers of quisqua- 
late. This could produce the generally higher K i 
values for synthetic preparations at the low affin- 
ity site if one isomer were significantly less potent 
than the other. The fact that the synthetic pre- 
paration K~ values at the high-affinity site are not 
significantly different from those for quisqualate 
preparations isolated from natural sources argues 
against this explanation. It is more parsimonious 
to attribute the variability in low affinity Ki val- 
ues to a variable incidence of detectable gluta- 
mate-like and aspartate-like contaminants. 
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We emphasize that the amount of contamina- 
tion is small, with all batches tested being pure to 
greater than 98%. However, at high concentrations 
of quisqualate, contaminants may achieve a rele- 
vant concentration and exert spurious effects. Be- 
cause glutamate has a high affinity for excitatory 
amino acid receptors relative to other available 
ligands, the problem of contaminant aspartate and 
especially glutamate may become important in 
certain experimental paradigms. Further, we have 
not been able to identify all of the contaminant 
peaks which we observe. The possibility exists that 
these unknown substances themselves possess af- 
finity for glutamate receptors, since they behave 
chromatographically similarly to known glutamate 
agonists (glutamate, aspartate, and quisqualate). 
These findings have the potential to explain the 
unexpected effects of quisqualate at NMDA re- 
ceptors. Foster and Fagg (1987) found that quis- 
qualate at high concentrations could interact with 
NMDA receptor binding. Olverman et al. (1984) 
have proposed that glutamate contamination might 
explain the apparent affinity of quisqualate for 
NMDA receptors. The data presented here are 
consistent with this proposal. Several groups have 
reported that at the single ion channel level, quis- 
qualate can infrequently produce channel open- 
ings characteristic of NMDA-type receptors 
(Christiansen and Nowak, 1987: Cull-Candy and 
Usowicz, 1987; Jahr and Stevens, 1987). If the 
quisqualate used was slightly contaminated with 
aspartate or glutamate, either of these compounds 
could effect openings of the NMDA-activated 
channel. 
Finally, the possibility arises that quisqualate 
may be a much more selective ligand for the 
quisqualate receptor than had previously been 
supposed. The development of more pure prepara- 
tions of quisqualate may permit a more precise 
pharmacological investigation of the glutamate re- 
ceptor subclasses. 
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